Rezaei Arezou, Farzadfard Azad, Amirahmadi Atefe, Alemi Maasoomeh, Khademi Mitra
School of Biology, Damghan University, Damghan, Iran; Institute of Biological Sciences, Damghan University, Damghan, Iran.
School of Biology, College of Science, University of Tehran, Tehran, Iran.
J Ethnopharmacol. 2015 Dec 4;175:567-616. doi: 10.1016/j.jep.2015.08.010. Epub 2015 Aug 14.
Complementary and alternative medicine has been increasingly used to treat chronic illnesses, such as diabetes mellitus. However, various limitations in terms of their application and efficacies exist. Furthermore, there is still much to be done to discover the right herbal medicine for diabetes.
This paper aims to evaluate previous herbal studies on the management of diabetes mellitus, to address their strengths and weaknesses and propose a general framework for future studies.
Data sources such as PubMed, ScienceDirect, Scopus, SpringerLink, and Wiley were searched, limited to Iran, using 36 search terms such as herbal, traditional, medicine, and phytopharmacy in combination with diabetes and related complications. Reviewed articles were evaluated regarding the use of botanical nomenclature and included information on (1) identity of plants and plant parts used, (2) the processing procedure, and (3) the extraction process. The main outcomes were extracted and then surveyed in terms of the efficacies of herbs in the management of diabetes mellitus. Then a comparative study was performed between Iranian and non-Iranian studies with respect to herbs best studied in Iran.
Of the 82 herbs studied in Iran, only six herbs were endemic and 19 were studied in detail. Although most of the reviewed herbs were found to decrease the level of blood glucose (BG) and/or glycated hemoglobin (HbA1C) in both Iranian and non-Iranian studies, information on their pharmacological mechanisms is scarce. However, the level of HbA1C was measured in a limited number of clinical trials or animal studies. Available information on both short- and long-term use of studied herbs on diabetes related complications and functions of involved organs as well as comorbid depression and/or simultaneous changes in lifestyle is also insufficient. Furthermore, little or no information on their phytochemical, toxicological, and herb-drug interaction properties is available. It is worth noting that the efficacy of the reviewed herbs has been studied scarcely in both humans and animals regarding both Iranian and non-Iranian studies. A significant number of reviewed articles failed to cite the scientific name of herbs and include information on the processing procedure and the extraction process.
Treatment of diabetes mellitus as a multifactorial disease using herbal medicines requires a comprehensive approach. In order to discover the right herbal medicine for the management of diabetes many other important factors than the levels of BG, HbA1C and insulin should be considered. According to our criteria, all the reviewed herbs suffered from inadequate investigation in human, animal and in vitro models in this respect, whereas they are worth investigating further. However, more research on endemic plants and the traditional history of herbal medicine is warranted. In our opinion, the pharmacological, toxicological, and phytochemical information should be obtained before clinical trials. Furthermore, information such as botanical scientific nomenclature, side effects, and toxicity will improve the quality and validity of publications in herbal research. In particular, designing a database covering all valid information about herbs and/or diseases will decrease unnecessary costs and increase the efficiency of research.
补充和替代医学已越来越多地用于治疗慢性疾病,如糖尿病。然而,其应用和疗效存在各种局限性。此外,要找到治疗糖尿病的合适草药仍有许多工作要做。
本文旨在评估以往关于糖尿病管理的草药研究,分析其优缺点,并为未来研究提出总体框架。
检索了PubMed、ScienceDirect、Scopus、SpringerLink和Wiley等数据源,搜索范围限定在伊朗,使用了36个搜索词,如草药、传统、医学、植物药学等,并与糖尿病及相关并发症相结合。对纳入的文章评估其植物学命名的使用情况,并包括以下信息:(1)所用植物及其部位的身份,(2)加工过程,(3)提取过程。提取主要结果,然后根据草药在糖尿病管理中的疗效进行调查。然后就伊朗研究最多的草药对伊朗和非伊朗研究进行比较研究。
在伊朗研究的82种草药中,只有6种是本土特有的,19种进行了详细研究。尽管在伊朗和非伊朗的研究中,大多数纳入的草药都能降低血糖(BG)水平和/或糖化血红蛋白(HbA1C)水平,但关于其药理机制的信息却很少。然而,在有限数量的临床试验或动物研究中测量了HbA1C水平。关于所研究草药对糖尿病相关并发症和受累器官功能的短期和长期使用情况,以及合并抑郁症和/或生活方式同时改变的现有信息也不足。此外,关于其植物化学、毒理学和草药-药物相互作用特性的信息很少或没有。值得注意的是,在伊朗和非伊朗的研究中,纳入草药在人类和动物中的疗效研究都很少。大量纳入的文章未能引用草药的科学名称,也未包括加工过程和提取过程的信息。
使用草药治疗作为一种多因素疾病的糖尿病需要综合方法。为了找到治疗糖尿病的合适草药,应考虑比BG、HbA1C和胰岛素水平更多的重要因素。根据我们的标准,所有纳入的草药在这方面在人体、动物和体外模型中的研究都不充分,然而它们值得进一步研究。然而,有必要对本土植物和草药的传统历史进行更多研究。我们认为,在进行临床试验之前应获取药理、毒理和植物化学信息。此外,诸如植物学科学命名、副作用和毒性等信息将提高草药研究出版物的质量和有效性。特别是,设计一个涵盖所有关于草药和/或疾病的有效信息的数据库将降低不必要的成本并提高研究效率。